The purpose of this study is to explore whether taking a version of the dietary supplement Anatabloc® exerts an effect on blood levels of amyloid beta (Aβ) or impacts global or functional measures of Alzheimer's disease in people with mild to moderate Alzheimer's. Outcomes for participants who take Anatabloc® lozenges two or three times per day will be compared with those of participants who take a placebo. The supplement is a naturally occurring, anti-inflammatory alkaloid.
|Min Age||Max Age||Gender||Healthy Volunteers|
|Map Marker||City||State||Zip Code||Status||Primary Contact|
Geolocation is 27.4081935, -82.5294065
Rock Creek Pharmaceuticals, Inc.
Roskamp Institute, Inc.
M. Varga, MD